These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31629301)

  • 21. NHS Health Checks for people with mental ill-health 2013-2017: an observational study.
    Garriga C; Robson J; Coupland C; Hippisley-Cox J
    Epidemiol Psychiatr Sci; 2020 Nov; 29():e188. PubMed ID: 33239117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving and standardizing metabolic screening for people prescribed antipsychotic medication who are at risk of developing metabolic syndrome within the community mental health setting.
    Hackett D; Fitzgerald C
    Int J Ment Health Nurs; 2020 Oct; 29(5):935-941. PubMed ID: 32567189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevalence of metabolic syndrome amongst patients with severe mental illness in the community in Hong Kong--a cross sectional study.
    Bressington DT; Mui J; Cheung EF; Petch J; Clark AB; Gray R
    BMC Psychiatry; 2013 Mar; 13():87. PubMed ID: 23506322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge.
    Marcus SC; Zummo J; Pettit AR; Stoddard J; Doshi JA
    J Manag Care Spec Pharm; 2015 Sep; 21(9):754-68. PubMed ID: 26308223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiometabolic comorbidity in antipsychotic treated patients: need for systematic evaluation and treatment.
    Steylen PM; van der Heijden FM; Kok HD; Sijben NA; Verhoeven WM
    Int J Psychiatry Clin Pract; 2013 Jun; 17(2):125-30. PubMed ID: 23437800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic Syndrome in South African Patients with Severe Mental Illness: Prevalence and Associated Risk Factors.
    Saloojee S; Burns JK; Motala AA
    PLoS One; 2016; 11(2):e0149209. PubMed ID: 26882230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of metabolic syndrome and its associated risk factors in an African-Caribbean population with severe mental illness.
    de Caluwé L; van Buitenen N; Gelan PJ; Crunelle CL; Thomas R; Casseres S; Matthys F; van Harten P; Cahn W
    Psychiatry Res; 2019 Nov; 281():112558. PubMed ID: 31546147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of care for cardiovascular disease and diabetes amongst individuals with serious mental illness and those using antipsychotic medications.
    Scott D; Platania-Phung C; Happell B
    J Healthc Qual; 2012; 34(5):15-21. PubMed ID: 22092725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular disease treatment among patients with severe mental illness: a data linkage study between primary and secondary care.
    Woodhead C; Ashworth M; Broadbent M; Callard F; Hotopf M; Schofield P; Soncul M; Stewart RJ; Henderson MJ
    Br J Gen Pract; 2016 Jun; 66(647):e374-81. PubMed ID: 27114210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of cardiovascular risk in an Italian psychiatric outpatient sample: A chart review of patients treated with second-generation antipsychotics.
    Severi E; Ferrara M; Tedeschini E; Vacca F; Mungai F; Amendolara R; Baccari F; Starace F
    Int J Ment Health Nurs; 2018 Jun; 27(3):1002-1008. PubMed ID: 29197134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physical health in schizophrenia: a challenge for antipsychotic therapy.
    Heald A
    Eur Psychiatry; 2010 Jun; 25 Suppl 2():S6-11. PubMed ID: 20620888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic monitoring and management among clozapine users.
    Tso G; Kumar P; Jayasooriya T; Kisely S; Siskind D
    Australas Psychiatry; 2017 Feb; 25(1):48-52. PubMed ID: 27590080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs.
    Correll CU; Frederickson AM; Kane JM; Manu P
    J Clin Psychiatry; 2006 Apr; 67(4):575-83. PubMed ID: 16669722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic syndrome and cardiovascular risk among institutionalized patients with schizophrenia receiving long term tertiary care.
    Seow LS; Chong SA; Wang P; Shafie S; Ong HL; Subramaniam M
    Compr Psychiatry; 2017 Apr; 74():196-203. PubMed ID: 28214752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The need for routine physical health care in schizophrenia.
    Montejo AL
    Eur Psychiatry; 2010 Jun; 25 Suppl 2():S3-5. PubMed ID: 20620884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular disease in patients with schizophrenia.
    Kritharides L; Chow V; Lambert TJ
    Med J Aust; 2017 Feb; 206(2):91-95. PubMed ID: 28152356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic Syndrome Screening in People With Severe Mental Illness: Results From Two Spanish Community Mental Health Centers.
    Fernández Guijarro S; Miguel García C; Pomarol-Clotet E; Egea López EN; Burjales Martí MD; Rigol Cuadra MA
    J Am Psychiatr Nurses Assoc; 2020; 26(2):162-171. PubMed ID: 30741068
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of Metabolic Syndrome in Drug-Naive Adolescents After 12 Months of Second-Generation Antipsychotic Treatment.
    Sjo CP; Stenstrøm AD; Bojesen AB; Frølich JS; Bilenberg N
    J Child Adolesc Psychopharmacol; 2017 Dec; 27(10):884-891. PubMed ID: 28783382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic syndrome in outpatients receiving antipsychotic therapy in routine clinical practice: a cross-sectional assessment of a primary health care database.
    Sicras-Mainar A; Blanca-Tamayo M; Rejas-Gutiérrez J; Navarro-Artieda R
    Eur Psychiatry; 2008 Mar; 23(2):100-8. PubMed ID: 17904825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome and cardiovascular risk between clozapine and non-clozapine antipsychotic users with schizophrenia.
    Quek YF; See YM; Yee JY; Rekhi G; Ng BT; Tang C; Lee J
    Asian J Psychiatr; 2022 Aug; 74():103192. PubMed ID: 35751958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.